Cell- and peptide-based immunotherapeutic approaches for glioma

Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration

Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour

Dendritic cell-based immunotherapy for malignant glioma

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy

Dendritic cell immunotherapy for malignant gliomas

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]

Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma

Use of interferon-alpha-induced dendritic cells in the therapy of patients with malignant brain gliomas